It is thought that rewarding experiences with drugs create strong contextual associations and encourage repeated intake. In turn, repeated exposures to drugs of abuse make lasting alterations in the brain function of vulnerable individuals, and these persistent alterations likely serve to maintain the maladaptive drug seeking and taking behaviors characteristic of addiction/dependence 2 . In rodents, reward experience and contextual associations are frequently measured using the conditioned place preference assay, or CPP, wherein preference for a previously drug-paired context is measured. Behavioral sensitization, on the other hand, is an increase in a drug-induced behavior that develops progressively over repeated exposures. Since sensitized behaviors can often be measured after several months of drug abstinence, depending on the dose and length of initial exposure, they are considered observable correlates of lasting drug-induced plasticity. Researchers have found these assays useful in determining the neurobiological substrates mediating aspects of addiction as well as assessing the potential of different interventions in disrupting these behaviors. This manuscript describes basic, effective protocols for mouse CPP and locomotor behavioral sensitization to cocaine.
Introduction
Research aimed at understanding drug addiction using animal models must take a variety of approaches to address each of the assorted components that obstruct treatment success, including reward/reinforcement/motivation and withdrawal and relapse, as well as the general persistence that further complicates these issues in addiction. Since rewarding experiences associated with taking a drug of abuse are thought to motivate subsequent use, studies focusing on drug-context associations may be particularly useful for understanding brain mechanisms that contribute to drug taking and seeking. One such assay, conditioned place preference (CPP) is a high-throughput method for comparing group differences in reward sensitivity. The traditional interpretation of the task involves classical, or Pavlovian, conditioning, where a conditioned stimulus (CS) is paired with an unconditioned stimulus (UCS), and after multiple pairings, the CS elicits the same behavior as the UCS (however, see 39, 40 ). Theoretically, animals learn to associate an interoceptive state (reward or aversion) with contextual cues. The relative aversive or appetitive intensity of the interoceptive state is then assessed by then determining the animal's preference for the contextual cues. The use of place conditioning to measure drug-reward associations dates back to at least 1957, to a study using morphine on rats in a Y-maze 3, 4 . Over the past several decades, variations on this method have been widely used to study place preference and aversion in rodents to various stimuli, and it remains particularly useful in the study of associations induced by drugs of abuse. In drug-addiction research, the assay has been used to assess the rewarding properties of a number of drugs and the contribution of different brain systems and proteins to drug reward (for reviews, see [5] [6] [7] 44 ). While there are superior methods of assessing factors that contribute to drug addiction, namely drug self-administration, CPP is a simple and much more accessible approach to measuring reward function.
Most current protocols for conditioned place preference and aversion (CPA) use an apparatus that allows rodents to have access to two distinct chambers, either via a doorway or smaller connecting chamber. Distinctions between the two chambers are often based, at a minimum, on visual and tactile cues, including wall color and floor texture, but sometimes include other elements, such as olfactory cues. "Biased" designs typically attempt to reverse a pre-existing, innate preference for one chamber over the other, such as the one that rodents generally show for a black chamber over white. "Unbiased" designs aim to create a preference to one of two chambers that were initially equally appealing by randomly counterbalancing assignment to either chamber within a group. A "balanced" design is used when animals show small preferences, but do not, as a group, favor the same chamber. Goals of this latter design are to produce 1) pre-test preference scores for the (eventual) cocaine-paired chamber that are not significantly different between experimental groups and 2) negligible preference for the cocaine-paired chamber at pre-test, either positive or negative 8 , and intracranial infusions 38 in a place preference apparatus have also been developed. These pairings are complemented by non-drug (vehicle) pairings of the same length conducted in the opposite chamber, which can take place on the same day as drug pairings or on separate days. In general, when allowed to explore the apparatus after conditioning, animals will spend more time where they received a rewarding drug (i.e., one that humans and animals will voluntarily self-administer), while they will avoid a place where they were given a drug that induced illness (e.g., lithium chloride). Several studies have been dedicated to optimizing the conditions for place preference to different drugs of abuse (for review, see
. Cocaine doses (i.p.) for mice generally range from 1 to 20 mg/kg, with doses less than 5 mg/kg often used to parse high sensitivity in one group. Two or more drug pairings are typically required for adult mice 10 , and the length of these pairings is an important consideration. Very low doses of cocaine require an immediate and brief conditioning, likely because this method captures the most rewarding period of the exposure. Delayed or very long conditioning periods can result in no preference, or may even induce aversion 11, 12 . Here is presented a basic method for obtaining conditioned place preference to cocaine in adult mice.
While the CPP assay is an ideal method for assessing reward-related learning and memory of drug-context associations, behavioral sensitization is arguably easier to perform and allows the assessment of changes that develop over repeated treatment. Also known as reversetolerance, behaviors undergoing sensitization are incrementally enhanced over repeated exposures to a particular drug of abuse, especially psychostimulants, and cross-sensitization is known to occur between some, but not all, of these drugs. One of the first assessments of cocaineinduced locomotor sensitization, in particular, in rodents was published in 1976 13 . A number of labs have shown that sensitized locomotion is detectable long after drug cessation, depending on the original length, location and dose of exposure [14] [15] [16] [17] , and the current protocol has been used to detect sensitization as long as 10 months following seven days (30 mg/kg) of cocaine treatment in mice 18 . The test can be performed using either photobeam or video-tracking technologies, in apparatuses of differing sizes and shapes, making it simple for many labs to perform. The robust nature, simplicity and persistence of locomotor sensitization makes its assessment an ideal part of examining basic mechanisms of long-lasting changes in drug-induced behavior.
As is expanded upon in the discussion, an important consideration when performing the locomotor sensitization assay is whether drug is given in the home-or test-cage environment. To take advantage of the robust sensitization that occurs when drug administration occurs outside of the home cage, this protocol employs this method. However, it has been observed that when animals are not adequately habituated to a new environment before drug exposure, a novelty-induced ceiling effect occurs on Day 1, which can partially or fully mask the progressive nature of sensitization. It is likely that this represents synergistic locomotor-activating effects of the drug together with novelty, and while the mechanisms underlying such effects may be interesting, the method described is designed to reduce the role of novelty and allow the effects of the drug to be measured more independently. While it is expected this method will be useful in the assessment of other locomotor-sensitizing drugs, it has primarily evaluated its effectiveness with cocaine in C57BL/6 mice.
Protocol
All experimental procedures have been approved by the McLean Hospital Institutional Animal Care and Use Committee. NOTE: The following protocol describes a single approach to CPP and locomotor sensitization, many details of which differ from other successful protocols (e.g., light-vs. dark-phase testing, consecutive vs. intermittent dosing, etc.). Novices may wish to begin with these protocols, or simply use them as guides, adapting alterations from the literature based on the experimental question(s) at hand. Automated measurement methods are described; however, it is possible to use non-automated means for each assay (i.e., video recording, hand-scoring).
Conditioned Place Preference

Equipment and Room Set-Up:
1. Handle experimental mice for 1-3 min each day, for at least 3-5 days prior to testing. NOTE: Never-handled mice may find removal from the chamber stressful, which can interfere with or alter conditioning. 2. Obtain four or more three-chambered CPP apparatuses, preferably equipped with photobeams for automated data collection 18 . Ensure that each chamber has two larger, visually-and tactilely-distinct chambers connecting to a smaller, neutral chamber via doors that can be raised/lowered to control access. Lids on each chamber should open for insertion/removal of mice and be mounted with small, individually controllable (dimmable) lights (one per chamber). NOTE: CPP chamber designs vary and can be purchased commercially or constructed by researchers. For the "balanced" design, a recommended scheme is one larger chamber with white walls and wire grid flooring and the other with black walls and bar flooring. The middle chamber should have gray walls and solid gray Plexiglass flooring. For explanation purposes, these chambers will be referred to as "white," "black" and "middle." Lids should be clear Plexiglass. Alternate compartment configurations (one-or two-chamber) are also possible and discussed elsewhere (see Discussion). 3. Setup the room as it will be during testing: turn off or set overhead lights to the dimmest setting and close the door. Use a light meter inside each chamber and set the lid lights so that middle chambers are slightly brighter (15-20 lux) than black and white chambers (6-10 lux) in order to discourage mice from spending time there. NOTE: If the average time spent in the middle is as much or more than in the black or white chambers, further increase the lighting contrast described in Step 1.1.3. Alternatively, use less appealing flooring for the middle. (e.g., ~220 0.5 cm diameter holes, evenly spaced in 6 x 3.5 x ¼" Plexiglass), but avoid making this chamber aversive. Pilot any alterations to ensure that decreases in middle time are not due to decreases in total explorations (crossings). 4. Program automated data collection ("procedure," Figure 1A) or manually collect data according to the following parameters. Set trials to start upon the first beam break in either conditioning chamber. Set "test" sessions to be 20 min in length and to track time spent and beam breaks in each chamber. Set "conditioning" sessions to be 30 min long and (optionally) to measure beam breaks in each chamber. Set all chamber lights to illuminate during trial.
6. Just prior to or following the pre-test, weigh the animals. Use these weights for dose calculations during conditioning. 7. In order to prepare for conditioning trials, calculate each mouse's pre-test "preference" for the black and white chambers by subtracting time spent in each of these from the other (i.e., "black minus white" & "white minus black"; see Figure 3 , Columns 9 & 10). 8. Since mice with strong initial preferences make balancing difficult, establish an acceptable limit for preference scores (e.g., <33% of total trial time) and exclude mice that exceed it from calculations. Use a liberal limit (<66% of total trial time) to maximize inclusion when attrition is likely after testing is complete (e.g., due to off-target surgical manipulations). NOTE: Mice exceeding the limit can still be tested, with an attempt to keep their pre-test preferences balanced. Later, these mice can be excluded from analysis, if necessary, to balance pre-test scores. If extreme pre-test biases (i.e., >800 sec) disproportionately affect one group, consider altering the conditioning environments and/or using other assays. 9. Choose the black or white chamber as the drug-pairing chamber for each mouse, meanwhile summing the corresponding pre-test preference scores within each group with the following priorities in mind: NOTE: Take care to balance scores between groups within each cohort as well as across any previous cohorts. 1. Make the sums for all groups as equivalent as possible. 2. Make the sums as close to zero as possible (i.e., choose the preferred side for some mice and the non-preferred side for others). If a near-zero sum is impossible for any given group, re-adjust all others to closely match the best obtainable score for the limiting group, favoring slightly negative group sums over positive. 3. As much as feasible, keep assignments of black versus white and preferred versus non-preferred chambers for drug pairings even within each group. 4. As it is not always possible to meet the above goals, correct any deviations by making opposing balancing considerations in later cohorts; however, try to avoid producing cohorts with wildly different average pre-test preferences. NOTE: Dose should be chosen with regard to experimental expectations, considerations mentioned in the Introduction, and potential floor and ceiling effects. It is often best to conduct independent experiments using at least two different doses. 12. Load "conditioning" computer program and enter animal IDs (Figure 1A) , then issue start command (Figure 1B) , if applicable. 13. Scruff and inject each mouse (i.p.), immediately lowering them into the appropriate black or white chamber of their assigned apparatus facing the back wall, then softly close the lid. Once all chambers are loaded, leave the testing room and minimize noise. 14. Remove mice from their chamber as close to exactly 30 min as feasible (i.e., the first mice are removed from their chambers while other mice are still conditioning). Remove animals as quietly as possible, without introducing noise.
3. Statistical Analysis: 1. Choose a method of analysis. Either subtract time spent on the saline-paired side during the post-test from time spent on the cocainepaired side during the post-test (cocaine -saline, sec) or use the time spent in the post-test drug-paired chamber minus the pre-test time spent on the drug-paired chamber. NOTE: if using the first method, also plot line graphs of average time spent in the middle, saline-and drug-paired chambers during the pre-and post-tests for each group. Compared to the pre-test, the post-test should show increased time in the drug-paired side and decreased time spent in the saline-paired side (see Figure 6 , bottom, and Discussion for explanation). 2. Depending upon the nature and number of groups being compared, use a t-test, One-or Two-Way ANOVA, as appropriate, possibly with post-hoc analysis, to analyze either of the above-presented subtraction scores. NOTE: Cocaine preference scores tend to be variable, and furthermore, can be negative (i.e., indicate aversion to the drug-paired side). Mice that show aversion should not be removed (unless they are statistical outliers), since this result is normal and likely important to determining differences between groups. Expect to need sample sizes of 12 to 30 animals per group, depending on the effect size of the treatment. 
Discussion
This protocol demonstrates methods for conditioned place preference and locomotor sensitization, each of which can be used by the average lab to assess aspects of drug-induced behavioral plasticity. As with most behavioral tests, there are additional worthy considerations beyond the basic protocol. First, each of these techniques can be conceived as having two phases, induction and expression. "Induction" covers the development of the behavior-for CPP it occurs during conditioning, and for sensitization it is the initial period of (typically consecutive) drug exposures. "Expression" for CPP is the post-test, while for sensitization it can be defined as a drug challenge given either after withdrawal or simply as the last consecutive exposure.
It is worthwhile to consider limiting manipulations to one of these phases versus the other to better parse their potential effects. Viruses with temporally limited effectiveness (e.g., HSV) or drug co-administrations/pretreatments (e.g., agonists/antagonists) are useful in such efforts. When taking this approach, it may be further necessary to use compressed protocols so that a particular phase will better coincide with viral expression. For CPP, it is possible to conduct a two-day conditioning method, as we have described previously 37 . Especially for locomotor sensitization, changes in the withdrawal period between induction and expression combined with these methods, may uncover processes involved in the maintenance or stability of the behavior. In addition, such approaches can be used to study the phenomenon of cross-sensitization, where a sensitized behavior is induced using one drug but can be expressed by exposure to a different drug. Since crosssensitization does not occur between all sensitizing drugs of abuse, may elicit a sensitized behavior that differs somewhat from the original, and is not necessarily bidirectional for any given set of drugs, its examination may offer unique opportunities to understand where and how different drugs affect brain plasticity and function.
Proper interpretation of CPP, in particular, depends upon ruling out alternative explanations of the findings. Data generated in a three-chambered apparatus should be further scrutinized before defining subtraction of time spent in the saline-paired side from the cocaine-paired side at posttest as preference, since an increase in a preference for the drug-paired side that results solely from a decrease in time spent in the saline-paired chamber is likely unfit for such an interpretation. The middle chamber allows for this result since the mouse may alter time spent there instead of the drug-paired chamber. It is also possible to observe increased time spent in the drug-paired side at the expense of the middle chamber instead of the saline-paired side; arguably, this outcome may still be acceptably interpreted as an increase in drug preference. The inclusion of third compartment provides a neutral chamber that allows unbiased placement of the animal during pre-and post-test sessions 41 . Although useful for addressing initial placement biases contributing to test-day scores, the third chamber is not required for conditioning. Alternative CPP designs that feature two distinct compartments or a single compartment with varied stimulus configurations are discussed elsewhere [41] [42] . Any deficit in place preference for a drug should also be accompanied by assessments of both ability to learn contextual associations and general reward function. There are a number of adjustments that can be made to the CPP paradigm that can aide in the interpretation of altered preference, including modifying the salience of the UCS (drug) by increasing (or decreasing) the number of pairings or using higher or lower drug dose. CPP can be performed using palatable food (e.g., high fat, sucrose) or social interactions to assess whether the observed change is specific to drug or is relevant to natural rewards; non-CPP approaches useful for this purpose include intracranial self-stimulation, sucrose preference, and/or appetitive approach tasks. However, all of these options vary in their ability to adequately address the desired question. Foodbased CPP may be particularly beneficial since normal responses demonstrate an ability to learn and form appropriate contextual associations with a natural reward. Additional controls for assessing learning ability include tasks that rely on contextual learning/memory (contextual fear conditioning and CPA). CPA has the advantage of being run similarly to CPP, often in the same chambers, replacing the appetitive drug with an aversive experience (e.g., lithium chloride injection). Animals that show deficits in CPP, but normal CPA, demonstrate an ability to form appropriate contextual associations, which indicates that impairments in drug CPP most likely relate to reward (drug-specific or otherwise). One caution for CPA using lithium chloride to consider is whether this drug is a known treatment for any condition that may be modeled by the experimental animals. For example, lithium treatment has been shown to counteract learning deficits in the mouse model of Fragile X 43 , which would confound this control method.
In addition to the classic CPP paradigm, there are potential extensions users may find useful, such as testing extinction of the learned drug-context association and its reinstatement after CPP. Conditioned responses (CRs), once established, can be maintained for extended periods 19, 20 when animals are left undisturbed. Despite the relative persistence of the CR, it can be effectively extinguished by repeated presentations of the CS (context) in the absence of the UCS (drug). Two CPP extinction methods appear in the literature: repeated test exposure without injection 21 or re-pairings of the previously drug-paired side with vehicle 22 . Extinction processes reflect new learning, as opposed to "unlearning" of the original conditioning, an idea effectively demonstrated through "reinstatement." Reinstatement is classically triggered by reexposure to the UCS, which produces recovery of the CR. In the context of CPP, a single injection of the training drug will cause animals to show place preference. Interestingly many non-training drug cues can also produce reinstatement of CPP, including priming with alternative drugs 22 and a variety of stressors [23] [24] [25] [26] . Extinction and reinstatement experiments are of particular interest to the drug addiction field as models of drug treatment and relapse. Interventions that improve the rate of extinction and/or reduce the magnitude of reinstatement could be valuable targets for human pharmacotherapies.
Compared to CPP, locomotor sensitization is considered to be much less dependent upon learning, and therefore, may be a preferred method for assessing drug-induced plasticity in rodent models with known cognitive difficulties. That said, there is certainly evidence that at least in some sensitization paradigms, a learned drug-context association develops and contributes to the sensitized response. Supporting evidence includes greater sensitization observed when drug is administered in a test environment outside of the home-cage, and sometimes, a lack of sensitization altogether when dosing occurs in the home-cage (e.g., [27] [28] [29] ). Notably however, context-independent sensitization has clearly been demonstrated in other studies (e.g., [30] [31] [32] ). Experimental details that may contribute to whether a context-dependent increase in sensitization is observable include drug dose, length of exposure, whether any group must be transported for the test of sensitization and certain aspects of preexposure to the testing chamber; however, these details remain somewhat unclear. One method of determining the contribution of contextual sensitization is to give a saline challenge following drug sensitization 33 . The use of the described paradigm minimizes the contribution of contextdependent sensitization as evidenced by very little locomotor activation in previous studies upon saline challenge. The contextual contribution to sensitization has been reviewed in a number of papers, often including discussions of behaviors other than locomotor activity 34 .
To limit contamination of drug-induced activation and sensitization with the locomotor stimulating effects induced by a novel environment, mice are acclimated to saline injections for three to four days at the beginning of each experiment. As can be seen in Figure 7 , mice typically show reduced locomotion between the first and last saline acclimation day. In addition, the mice are noticeably calmer and easier to handle and inject by the last saline exposure. Previous works have tested multiple strains and genotypes of mice using this paradigm and do not see much variance in saline acclimation activity across them; however, it is possible to occasionally observe very strong hyperactivity phenotypes associated with particular genotypes that are not overcome using this method. In these cases, it may be desirable to perform several saline acclimation days (until locomotion plateaus in the hyperactive group), and then normalize the hyperactive group to the control group using the last saline injection day data. While not ideal, it allows for a more reasonable comparison of the effects of a drug on locomotion between these groups. Other options that may allay extreme hyperactivity are to extend the habituation trial length prior to injection each day by one to 5 hr, and/or use longer injection trials (2 -4 hr) each day.
There are additional considerations that are important to the interpretation of locomotor behavior. As illustrated in Figure 7C , observed group differences may be driven primarily by disparities in the acute locomotor response, the rate of sensitization over days, the maximal limit of sensitization, or some combination of these factors. Parsing the contributions of these factors individually can be helpful. For this purpose, the acute locomotor response can be statistically analyzed alone. Then the rate of sensitization can be assessed using a program capable of curve fitting and a rate normalization process that discounts any acute locomotor differences. Altered maximal sensitization is usually revealed in a RM ANOVA over the consecutive drug exposure days, where follow-up day-by-day post-hoc comparisons are significant on days after group responses have plateaued. One should be aware that maximal sensitization cannot be determined for any group that maintains a linear locomotor response over drug exposure days, such as portrayed in Figure 7C (middle; blue line). In such a case, drug exposure may be extended to try and determine maximal sensitization.
Lastly, it is typically best to compare sensitization between groups using at least two primary drug doses performed in separate cohorts of animals. Differences in any of the above aspects of locomotor activation, at one dose or both, should be used to guide further testing to rule out other explanations, including alterations in the development of stereotypy. Repeated exposure to some drugs, such as cocaine and amphetamine, not only produces sensitized locomotion in a dose-dependent manner, but also sensitizes competing stereotypical behaviors. These stereotypies become particularly overt at high doses, such that locomotor sensitization is often partially or completely obscured, but revealed again upon administration of a lower dose. For this reason, a "deficit" in locomotor sensitization in one experimental group may actually reflect heightened sensitivity to the drug-induced development of stereotypies. The assessment of stereotypy can be challenging, but there are a number of published scales 35 and other approaches 36 . Using both a general stereotypy scale and an assessment of specific behaviors is recommended, as published previously 18 .
In conclusion, a number of behavioral tests have been developed in animal models in an attempt to parse the complexity of human addiction. Conditioned place preference and locomotor sensitization are two basic tests widely used in rodents and, respectively, they may be particularly useful in the assessment of early drug-associated reward and the persistent plasticity induced by repeated use. There are a number of considerations for the design and interpretation of each type of study, making it worthwhile to carefully consider the experimental goals and previous literature when planning these assessments.
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